Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.04 USD
Change Today +0.001 / 2.44%
Volume 22.2K
As of 10:12 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

pharmos corp (PARS) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/6/14 - $0.31
52 Week Low
10/23/14 - $0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PHARMOS CORP (PARS)

Related News

No related news articles were found.

pharmos corp (PARS) Related Businessweek News

No Related Businessweek News Found

pharmos corp (PARS) Details

Pharmos Corporation, a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in Iselin, New Jersey.

2 Employees
Last Reported Date: 02/17/12
Founded in 1990

pharmos corp (PARS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PARS:US $0.04 USD +0.001

PARS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PARS.
View Industry Companies

Industry Analysis


Industry Average

Valuation PARS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMOS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at